Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George J Netto

Showing results (221-230 of 315) with videos related to

Pageof 32
Sort By:
Frontiers in Oncology|June 9, 2020
Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder CancerYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Oncotarget|January 18, 2019
Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliabilityEnrico Munari, Giuseppe Zamboni, Marcella Marconi, et al.
The American Journal of Surgical Pathology|September 5, 2014
GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utilityNatalie Banet, Allen M Gown, Ie-Ming Shih, et al.
Oncotarget|November 23, 2017
PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliabilityEnrico Munari, Giuseppe Zamboni, Marcella Marconi, et al.
International Journal of Molecular Sciences|August 6, 2020
Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial CarcinomaEisuke Tomiyama, Kazutoshi Fujita, Maria Del Carmen Rodriguez Pena, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 12, 2011
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomasAntoun Toubaji, Roula Albadine, Alan K Meeker, et al.
Histopathology|May 3, 2022
An introduction to the WHO 5th edition 2022 classification of testicular tumoursDaniel M Berney, Ian Cree, Vishal Rao, et al.
Plos One|January 6, 2016
Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical ProstatectomySheila F Faraj, Stephania M Bezerra, Kasra Yousefi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 15, 2015
Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical useChristina Michailidi, Masamichi Hayashi, Sayantan Datta, et al.
Histopathology|August 9, 2022
What's new in WHO fifth edition - urinary tractEva Compérat, Mahul B Amin, Dan M Berney, et al.
Pageof 32

Showing results (221-230 of 315) with videos related to

Sort By:
Pageof 32
Frontiers in Oncology|June 9, 2020
Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder CancerYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Oncotarget|January 18, 2019
Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliabilityEnrico Munari, Giuseppe Zamboni, Marcella Marconi, et al.
The American Journal of Surgical Pathology|September 5, 2014
GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utilityNatalie Banet, Allen M Gown, Ie-Ming Shih, et al.
Oncotarget|November 23, 2017
PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliabilityEnrico Munari, Giuseppe Zamboni, Marcella Marconi, et al.
International Journal of Molecular Sciences|August 6, 2020
Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial CarcinomaEisuke Tomiyama, Kazutoshi Fujita, Maria Del Carmen Rodriguez Pena, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 12, 2011
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomasAntoun Toubaji, Roula Albadine, Alan K Meeker, et al.
Histopathology|May 3, 2022
An introduction to the WHO 5th edition 2022 classification of testicular tumoursDaniel M Berney, Ian Cree, Vishal Rao, et al.
Plos One|January 6, 2016
Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical ProstatectomySheila F Faraj, Stephania M Bezerra, Kasra Yousefi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 15, 2015
Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical useChristina Michailidi, Masamichi Hayashi, Sayantan Datta, et al.
Histopathology|August 9, 2022
What's new in WHO fifth edition - urinary tractEva Compérat, Mahul B Amin, Dan M Berney, et al.
Pageof 32